CoChat
Sign Up
Cited by 122

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

RETRACTED: LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway

Fu, Chao, Li, Dongyuan, Zhang, Xiaonan, Liu, Naijie, Chi, Guonan, Jin, Xingyi·2018·Neurotherapeutics
DOI 10.1007/s13311-018-0649-9
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13311-018-0649-9This paper is marked retracted.

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 52

  1. Valadez, 2014, Primary orthotopic glioma xenografts recapitulate infiltrative growth and isocitrate dehydrogenase I mutation, J Vis Exp, 10.3791/50865-v · DOI
  2. Moncayo, 2018, SYK inhibition blocks proliferation and migration of glioma cells, and modifies the tumor microenvironment, Neuro Oncol, 10.1093/neuonc/noy008 · DOI
  3. Lu, 2018, MicroRNA-370 suppresses the progression and proliferation of human astrocytoma and glioblastoma by negatively regulating beta-catenin and causing activation of FOXO3a, Exp Ther Med, 15, 1093
  4. Wu, 2018, MAD2-p31(comet) axis deficiency reduces cell proliferation, migration and sensitivity of microtubule-interfering agents in glioma, Biochem Biophys Res Commun, 498, 157, 10.1016/j.bbrc.2018.02.011 · DOI
  5. Zou, 2017, lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients, Oncotarget, 8, 78767, 10.18632/oncotarget.20226 · DOI
  6. Nagano, 2011, No-nonsense functions for long noncoding RNAs, Cell, 145, 178, 10.1016/j.cell.2011.03.014 · DOI
  7. Schaukowitch, 2014, Emerging epigenetic mechanisms of long non-coding RNAs, Neuroscience, 264, 25, 10.1016/j.neuroscience.2013.12.009 · DOI
  8. Hu, 2014, A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer, Cancer Cell, 26, 344, 10.1016/j.ccr.2014.07.009 · DOI
  9. Ke, 2017, The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer, Oncotarget, 8, 21516, 10.18632/oncotarget.15628 · DOI
  10. Cai, 2015, The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144, Oncotarget, 6, 19759, 10.18632/oncotarget.4331 · DOI
  11. Ding, 2015, Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients, Oncol Lett, 9, 955, 10.3892/ol.2014.2730 · DOI
  12. Ma, 2017, PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186, Tumour Biol, 39, 10.1177/1010428317694326 · DOI
  13. Franzoni, 2015, miR-128 regulates neuronal migration, outgrowth and intrinsic excitability via the intellectual disability gene Phf6, Elife, 4, 10.7554/eLife.04263 · DOI · Paper page
  14. Li, 2015, miR-23a binds to p53 and enhances its association with miR-128 promoter, Sci Rep, 5
  15. Zhu, 2011, Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5, Clin Cancer Res, 17, 7105, 10.1158/1078-0432.CCR-11-0071 · DOI · Paper page
  16. Zhu, 2011, Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract, Exp Ther Med, 2, 27, 10.3892/etm.2010.164 · DOI
  17. Sun, 2015, miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1, Jpn J Clin Oncol, 45, 474, 10.1093/jjco/hyv027 · DOI
  18. Evangelisti, 2009, MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness, FASEB J, 23, 4276, 10.1096/fj.09-134965 · DOI · Paper page
  19. Li, 2011, Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas, OMICS, 15, 673, 10.1089/omi.2011.0064 · DOI
  20. Zhang, 2009, MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a, J Mol Med (Berl), 87, 43, 10.1007/s00109-008-0403-6 · DOI · Paper page
  21. Weiss, 2008, EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines, Ann Oncol, 19, 1053, 10.1093/annonc/mdn006 · DOI
  22. She, 2014, miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma, Oncol Rep, 32, 957, 10.3892/or.2014.3318 · DOI
  23. Dong, 2014, An axis involving SNAI1, microRNA-128 and SP1 modulates glioma progression, PLoS One, 9
  24. Church, 2015, Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7, Biochem J, 466, 55, 10.1042/BJ20140771 · DOI
  25. Bayne, 2016, BMP signalling in human fetal ovary somatic cells is modulated in a gene-specific fashion by GREM1 and GREM2, Mol Hum Reprod, 22, 622, 10.1093/molehr/gaw044 · DOI
  26. Rodrigues-Diez, 2014, Gremlin activates the Smad pathway linked to epithelial mesenchymal transdifferentiation in cultured tubular epithelial cells, Biomed Res Int, 2014, 10.1155/2014/802841 · DOI
  27. Jang, 2017, Prognostic significance of stromal GREM1 expression in colorectal cancer, Hum Pathol, 62, 56, 10.1016/j.humpath.2016.12.018 · DOI
  28. Kim, 2017, GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas, PLoS One, 12
  29. Mulvihill, 2012, Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells, PLoS One, 7, 10.1371/journal.pone.0042264 · DOI
  30. Guan, 2017, Gremlin1 promotes carcinogenesis of glioma in vitro, Clin Exp Pharmacol Physiol, 44, 244, 10.1111/1440-1681.12697 · DOI
  31. Yan, 2014, Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy, Genes Dev, 28, 1085, 10.1101/gad.235515.113 · DOI
  32. Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R Stat Soc Series B Stat Methodol, 57, 289, 10.1111/j.2517-6161.1995.tb02031.x · DOI · Paper page
  33. Izaurralde, 2012, Elucidating the temporal order of silencing, EMBO Rep, 13, 662, 10.1038/embor.2012.91 · DOI
  34. Wang, 2015, Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway, Oncotarget, 6, 7899, 10.18632/oncotarget.3219 · DOI
  35. Jaeger, 2012, Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1, Nat Genet, 44, 699, 10.1038/ng.2263 · DOI
  36. Zhou, 2016, Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195, Oncotarget, 7, 82620, 10.18632/oncotarget.13012 · DOI
  37. Gao, 2017, Long noncoding RNA PVT1 facilitates cervical cancer progression via negative regulating of miR-424, Oncol Res, 25, 1391, 10.3727/096504017X14881559833562 · DOI
  38. Guo, 2018, Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression, Exp Cell Res, 362, 172, 10.1016/j.yexcr.2017.11.014 · DOI
  39. Zhao, 2018, LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448, J Cell Physiol, 233, 4044, 10.1002/jcp.26072 · DOI
  40. Xue, 1864, PVT1 regulates the malignant behaviors of human glioma cells by targeting miR-190a-5p and miR-488-3p, Biochim Biophys Acta, 2018, 1783
  41. Yang, 2017, Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2, Biosci Rep, 37, 10.1042/BSR20170871 · DOI
  42. Das, 2014, lnCeDB: database of human long noncoding RNA acting as competing endogenous RNA, PLoS One, 9, 10.1371/journal.pone.0098965 · DOI
  43. Hu, 2014, microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C, Eur J Cancer, 50, 2336, 10.1016/j.ejca.2014.06.005 · DOI
  44. Li, 2014, Deregulation of miR-128 in ovarian cancer promotes cisplatin resistance, Int J Gynecol Cancer, 24, 1381, 10.1097/IGC.0000000000000252 · DOI
  45. Shi, 2012, MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1, PLoS One, 7
  46. Khan, 2010, Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer, Mol Cell Proteomics, 9, 298, 10.1074/mcp.M900159-MCP200 · DOI
  47. Rider, 2010, Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists, Biochem J, 429, 1, 10.1042/BJ20100305 · DOI
  48. Alborzinia, 2013, Quantitative kinetics analysis of BMP2 uptake into cells and its modulation by BMP antagonists, J Cell Sci, 126, 117, 10.1242/jcs.109777 · DOI
  49. Sun, 2006, BMP4 activation and secretion are negatively regulated by an intracellular gremlin-BMP4 interaction, J Biol Chem, 281, 29349, 10.1074/jbc.M603833200 · DOI
  50. Sato, 2016, Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance, Oncol Rep, 35, 391, 10.3892/or.2015.4367 · DOI
  51. Karagiannis, 2013, Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1, Mol Oncol, 7, 826, 10.1016/j.molonc.2013.04.002 · DOI
  52. Kisonaite, 2016, Structure of Gremlin-1 and analysis of its interaction with BMP-2, Biochem J, 473, 1593, 10.1042/BCJ20160254 · DOI

Cited by

Sorted by citations

Metadata

Authors
Fu, C., Li, D., Zhang, X., Liu, N., Chi, G., & Jin, X.
ORCID
Jin, Xingyi
Venue
Neurotherapeutics
Publisher
Elsevier BV
Published
2018-10
Volume
15
Issue
4
Pages
1139-1157
ISSN
1878-7479
DOI
10.1007/s13311-018-0649-9
Cited by
122
References
1
Language
en
Status
Retracted
Update notices
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review